Regenxbio Inc Revenue per Employee (RGNX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Regenxbio Inc   (NASDAQ: RGNX)
 

Regenxbio Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 405.73% in the second quarter 2026, year on year to cumulative value of $174 million, Regenxbio Inc 's revenue per employee grew on a trailing twelve months basis to $ 470,302. The productivity of Regenxbio Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 364 other companies have achieved higher revenue per employee. While Regenxbio Inc 's total ranking has deteriorated compared to the previous quarter from 2503 to 2829. Regenxbio Inc has 371 employees.


What is Sales per Employee Ratio?







RGNX Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 405.73 % -92.82 % 43 % 22.88 % -4.2 %
Sales per Employee (TTM) $ 470,302 236,717 459,410 434,819 419,898
RGNX's Total Ranking # 2829 # 2503 # 1331 # 908 # 1564
Seq. Revenue Change 1589.64 % -78.93 % 2.03 % 39.21 % -76 %


Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 43
Healthcare Sector # 365
Overall Market # 2829

Revenue per Employee Statistics
High Average Low
$ 1,305,377 $ 345,797 $ 12,369
(Jun 30 2022)   (Dec 31 2016)



Financial Statements
Regenxbio Inc 's Revenue MRQ $ 108 Millions Visit RGNX's Income Statement
Regenxbio Inc 's Revenues TTM $ 174 Millions Visit RGNX's aggregate revenue growth
What are RGNX's Sales? Visit RGNX's Sales by Segment




Other Ratios
Regenxbio Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
RGNX's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for RGNX's Competitors
Revenue per Employee for RGNX's Suppliers
Revenue per Employee for RGNX's Customers

You may also want to know
RGNX's Sales Growth Rates RGNX's Pe Price to earnings ratio RGNX's Receivables Turnover Ratio RGNX's Stock Quote
RGNX's Net Income Growth Rates RGNX's Ps Price to Sales ratio RGNX's Sales per Employee RGNX's Asset Turnover Ratio
RGNX's Net Margin RGNX's Pb Price to Book ratio RGNX's Financial Strength Ratios RGNX's Dividend Payout Ratio
Date modified: 2026-09-03T21:13:21+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Immunocore Holdings Plc  822,089.69 $ 430.775  Million 524 
Prothena Corporation Public Limited Company  813,880.60 $ 54.530  Million 67 
Alkermes Plc   813,488.78 $ 1,667.652  Million 2,050 
Lifevantage Corp  811,421.52 $ 180.947  Million 223 
Sanuwave Health Inc   798,236.36 $ 43.903  Million 55 
Geron Corporation  791,864.34 $ 204.301  Million 258 
Adma Biologics Inc   789,697.06 $ 510.934  Million 647 
Vericel Corporation  769,605.53 $ 306.303  Million 398 
Cerus Corporation  768,138.89 $ 221.224  Million 288 
Septerna Inc   760,630.77 $ 98.882  Million 130 
Dyadic International Inc   760,447.40 $ 3.802  Million
Transmedics Group Inc   744,396.44 $ 668.468  Million 898 
Aveanna Healthcare Holdings Inc   743,662.86 $ 2,602.820  Million 3,500 
Veracyte Inc   721,503.31 $ 544.735  Million 755 
Xtant Medical Holdings Inc   720,185.43 $ 108.748  Million 151 
Harrow Inc   719,172.77 $ 274.724  Million 382 
Ars Pharmaceuticals Inc   717,343.56 $ 116.927  Million 163 
Sunshine Biopharma Inc   706,935.44 $ 35.347  Million 50 
Johnson and Johnson  695,518.47 $ 97,929.000  Million 140,800 
Inspire Medical Systems inc   674,588.90 $ 899.227  Million 1,333 
Mannkind Corporation  664,915.54 $ 393.630  Million 592 
Intuitive Surgical Inc   663,668.41 $ 11,296.300  Million 17,021 
Biolife Solutions Inc   662,696.77 $ 102.718  Million 155 
Zoetis Inc   656,344.83 $ 9,517.000  Million 14,500 
Urogen Pharma Ltd   647,137.46 $ 188.317  Million 291 
Insmed Inc  646,978.37 $ 1,076.572  Million 1,664 
Phathom Pharmaceuticals Inc   645,991.91 $ 239.663  Million 371 
Premier Air Charter Holdings Inc   644,120.78 $ 31.562  Million 49 
Karyopharm Therapeutics Inc   643,074.56 $ 146.621  Million 228 
Evofem Biosciences Inc   622,241.38 $ 18.045  Million 29 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.